Brandi Roberts insider trades: Definium Therapeutics (DFTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brandi reports to the SEC
and 4 more companies
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | DFTX | ↓ Sell | 3,377 | $36.57 | $123K | Direct | Sep 29, 2026 (4d) |
| Aug 15, 2023 | TFFP | ↑ Buy | 20,000 | $0.25 | $5K | Direct | Aug 15, 2023 (0d) |
| Aug 13, 2019 | LCTX | ↑ Buy | 5,000 | $1.01 | $5K | Direct | Aug 15, 2019 (2d) |
| Jun 29, 2018 | RVA.AX | ↑ Buy | 4,908 | $1.53 | $8K | Direct | Jul 2, 2018 (3d) |
| Mar 27, 2015 | MSTX | ↑ Buy | 38,000 | $0.50 | $19K | Direct | Mar 30, 2015 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DFTX insiders
Open-market trades in the last 12 months
About Brandi Roberts's insider trades
Brandi Roberts is Chief Financial Officer at Definium Therapeutics (DFTX). Since Mar 27, 2015, Brandi has reported 4 open-market purchases worth $37K and 1 sale worth $123K on SEC Form 4. In the last 12 months: 1 sale ($123K).
Their filings also include grants and awards (28 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DFTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.